Singapore's leading Digital Health Solution firm ResMed has launched its new advanced manufacturing centre on November 16 located at the prime industrial location Tuas, Singapore.

The 270,000-square-foot facility is more than doubles the size of ResMed’s footprint in Singapore and serves as ResMed’s key manufacturing hub in Asia-Pacific. The facility will account for nearly 1,000 jobs and features smart dashboards that integrates real-time data to monitor the performance of production lines.

The facility has the manufacturing capacity and footprint to scale production for connected devices and mask systems to help people sleep, breathe, and live better lives – particularly people worldwide with sleep apnea, a chronic disease affecting an estimated 936 million people worldwide – including nearly 2.3 million people in Singapore, according to Lancet Respiratory Medicine. ResMed’s AirSense 11, the company’s latest PAP (positive airway pressure) device that allows users to monitor their own sleep apnea treatment via the myAir app, will be produced in this facility.

“Singapore’s strategic location and support for business investment, coupled with ResMed’s world-leading devices and digital health offerings, provides the perfect opportunity to expand our manufacturing capabilities while supporting local jobs and the region’s economy,” said ResMed CEO Mick Farrell. “The opening of this facility supports the continued growth of ResMed’s product portfolio to meet the needs of millions of people across Singapore, Asia-Pacific, and the world.”

ResMed has been operating in Singapore for over a decade, and will continue to grow regional teams across manufacturing, product development, operations, corporate, and commercial functions.

The grand opening of the advanced manufacturing centre is officiated by guest of honor and Singapore Senior Minister Tharman Shanmugaratnam, along with Australia’s High Commissioner to Singapore William Hodgman and U.S. Ambassador to Singapore Jonathan Kaplan.